TRIENTINE-REDDY'S trientine dihydrochloride 250 mg capsule bottle

Pajjiż: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

trientine dihydrochloride

Disponibbli minn:

Dr Reddys Laboratories Australia Pty Ltd

Għamla farmaċewtika:

Capsule

Kompożizzjoni:

Excipient Ingredients: iron oxide yellow; titanium dioxide; Gelatin; magnesium stearate; purified water; macrogol 3350; colloidal anhydrous silica

Rotta amministrattiva:

Oral

Unitajiet fil-pakkett:

100

Tip ta 'preskrizzjoni:

(S4) Prescription Only Medicine

Indikazzjonijiet terapewtiċi:

Trientine dihydrochloride capsules are indicated for the treatment of patients with Wilson's disease who are intolerant of penicillamine.

Sommarju tal-prodott:

Visual Identification: Yellow opaque, hard gelatin size 1 capsules imprinted with RDY on cap and 459 on body in black ink filled with white to pale yellow powder.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 36 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

L-istatus ta 'awtorizzazzjoni:

Registered

Data ta 'l-awtorizzazzjoni:

2021-03-29